Kejriwal highlights Indian pharma sector for smart investors

Market expert Arun Kejriwal has shared his insights on the Indian stock market. He believes the market is becoming more attractive, especially for large-cap stocks. However, he advises caution and recommends that investors wait before making major purchases. Kejriwal highlights the pharmaceutical sector as being in a "sweet spot." India plays a significant role in the global pharmaceutical market, mainly through the export of generic drugs. He noted that higher duties on these drugs are usually passed on to consumers. The banking sector also looks promising, according to Kejriwal. He emphasizes that the banking, financial services, and insurance (BFSI) sector is crucial to the Nifty index. He suggests that investors consider large-cap banking stocks and the housing finance segment. When discussing mid- and small-cap stocks, Kejriwal warns they are high-risk investments. In uncertain times, he advises focusing on safety, which large caps can provide. He encourages investors to rethink their portfolios after recent market trends. Kejriwal also touched on public sector undertakings (PSUs). He noted that segments like defense, railways, and power have attracted many new investors. Some stocks in these areas have seen dramatic increases. However, he cautions that there may still be challenges ahead for these stocks.